Percutaneous femoral venous cannulation is a vital skill for cardiac surgeons, especially in complex procedures such as redo sternotomy and ECMO. This video demonstrates the key technical steps for insertion of the cannula, such as the groin anatomy and identification of vessels using ultrasound.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Extracorporeal circulation
August 29, 2024
The optimal revascularization strategy after extracorporeal cardiopulmonary resuscitation (ECPR) remains unclear, with limited existing data.
June 13, 2024
The COMICS trial is the largest randomized trial of minimally invasive extracorporeal circulation (MiECC) compared to conventional ECC (CECC). MiECC reduced the frequency of SAEs prespecified to qualify for the primary outcome.
May 20, 2024
This video describes the process of patient selection and bedside percutaneous VA ECMO decannulation.
May 18, 2024
Succinct but comprehensive expert viewpoint on Support in Cardiogenic Shock vis -a -vis the manuscript of DanGer trial on promising results of Impella in highly selected subgroup (360 patients in a decade). The important point made is that of careful selection
May 2, 2024
Aortic valve regurgitation (AR) often occurs after left ventricular assist device (LVAD) implantation. Transcatheter aortic valve implantation (TAVI) is a viable alternative to surgical aortic valve replacement (SAVR) in this cohort, most of whom have a high surgical risk profile. Procedure outcome and survival were analyzed.
May 2, 2024
A fifty-four-year-old woman became the first person to simultaneously receive a gene-edited pig kidney transplant and mechanical heart valve implantation. Surgeons performed the heart pump procedure first before performing the transplant days later.
April 18, 2024
This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy undergoing surgical revascularization.
January 11, 2024
In this article, the author describes three patients who had undergone previous mitral and aortic valve replacement, experiencing cardiogenic shock due to valve dysfunction. The initial evaluation demonstrated that the patients were deemed inoperable based on risk score calculations.